Merck & Company Inc - End Period Cash Flow

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "End-Period-Cash-Flow" stands at 48.38 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2014.

Merck & Company Inc's third quarter result of 18.26 Billion USD for the item "End Period Cash Flow" represents an increase of 126.19 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of 18.26 Billion USD for the item "End Period Cash Flow" represents an increase of 24.32 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 48.38 Billion USD for the item "End Period Cash Flow" represents an increase of 7.97 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 25.21 percent compared to the value the year prior.
The 1 year change in percent is 25.21.
The 3 year change in percent is 27.95.
The 5 year change in percent is 34.61.
The 10 year change in percent is 61.86.

The Serie's long term average value is 39.48 Billion United States Dollars. It's latest available value, on 09/30/2025, is 22.54 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2018, to it's latest available value, on 09/30/2025, is +103.99%.
The Serie's change in percent from it's maximum value, on 09/30/2012, to it's latest available value, on 09/30/2025, is -22.34%.